COVID-19 US Information Center
Novartis is responding to COVID-19 with the safety of our associates and patients we serve as our main concern. We continue to contribute to global research efforts, support local communities and ensure stable supply and price of essential medicines. This US information center provides updates, guidance and other resources.
Information update about the Novartis CAN-COVID trial

Life Science Companies and the Bill & Melinda Gates Foundation: Joint Communique

Novartis US response to COVID-19

Novartis US COVID-19 Initiatives

Coronavirus disease (COVID-19) Global updates

Novartis COVID-19 Global Information Center

Novartis is responding to the coronavirus disease (COVID-19) outbreak. The information center provides a central hub for news, guidance and resources.